Open AccessClinical factors associated with hepatitis B screening and vaccination in high-risk adults
Author(s) -
Rotimi Ayoola,
Sebastian Larion,
David M. Poppers,
Reneé Williams
Publication year - 2019
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v11.i1.86
Subject(s) - medicine , hepatitis b , hepatitis b virus , hepatocellular carcinoma , vaccination , hepatitis c , liver disease , hepatitis , viral hepatitis , immunology , virus
Hepatitis B virus is a viral infection that can lead to acute and/or chronic liver disease, and hepatocellular carcinoma (HCC). Hepatitis B vaccination is 95% effective in preventing infection and the development of chronic liver disease and HCC due to hepatitis B. In 2011, the Centers for Disease Control updated their guidelines recommending that adults at high-risk for hepatitis B infection be vaccinated against hepatitis B including those with diabetes mellitus (DM). We hypothesize that adults at high-risk for hepatitis B infection are not being adequately screened and/or vaccinated for hepatitis B in a large urban healthcare system.